Gufic BioSciences Ltd Quarterly Results

Gross Sales

207.79

204.18

202.81

194.99

201.78

Excise Duty

0

0

0

0

0

Net Sales

207.79

204.18

202.81

194.99

201.78

Other Operating Income

0

0

0

0

0

Other Income

1.86

0.11

1.25

0.88

0.42

Total Income

209.66

204.29

204.07

195.87

202.2

Total Expenditure

173.87

165.56

167.03

160.77

165.32

PBIDT

35.79

38.73

37.03

35.11

36.88

Interest

4.91

5.18

4.62

3.65

3.18

PBDT

30.88

33.55

32.41

31.46

33.7

Depreciation

4.62

4.3

4.31

4.34

4.14

Minority Interest Before NP

0

0

0

0

0

Tax

3.95

7.5

7

7.3

7.2

Deferred Tax

3.01

-0.01

0.25

-0.23

0.1

Reported Profit After Tax

19.31

21.77

20.86

20.05

22.26

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

19.31

21.77

20.86

20.05

22.26

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

19.31

21.77

20.86

20.05

22.26

EPS (Unit Curr.)

1.93

2.17

2.08

2

2.23

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

10.03

10.03

10.03

10.03

10.03

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

17.22

18.96

18.25

18

18.27

PBDTM(%)

14.86

16.43

15.98

16.13

16.7

PATM(%)

9.29

10.66

10.28

10.28

11.03